58 results
Page 2 of 3
425
eeuf89voba8gkuxfjo
16 Jun 23
Business combination disclosure
8:08am
425
dbk4c60yogy5kz g1
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-99.1
v1pz3pkxvw0q99jr2awf
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-99.1
cdjm4
8 May 23
Coherus BioSciences Reports First Quarter 2023 Financial Results and Business Highlights
4:16pm
8-K
EX-99.1
rutgf7o zhx
8 Nov 22
Coherus BioSciences Reports Third Quarter 2022 Results and Provides Business Update
4:01pm
8-K
EX-99.1
i0jd79bsl4h
4 Aug 22
Coherus BioSciences Reports Second Quarter 2022 Results and Provides Business Update
4:25pm
8-K
EX-99.1
jlsuh58zpq48u2x
5 May 22
Coherus BioSciences Reports First Quarter 2022 Results
12:00am
8-K
EX-99.1
ako0xi9n
17 Feb 22
Coherus BioSciences Reports Fourth Quarter and Full Year 2021 Results
4:39pm
8-K
EX-99.1
w116 ozycr06pzp82db
13 Jan 22
Entry into a Material Definitive Agreement
4:39pm
8-K
EX-99.1
x29kbroqxyxwe hfa
8 Nov 21
Coherus BioSciences Reports Third Quarter 2021 Results
4:06pm
8-K
EX-99.1
x5iq3
5 Aug 21
Coherus BioSciences Reports Second Quarter 2021 Financial Results and Immuno-oncology and Biosimilar Pipeline Progress
4:06pm
8-K
EX-99.1
vlypq67dqvksa9j55p
6 May 21
Coherus BioSciences Reports First Quarter 2021 Financial Results and Immuno-oncology and Biosimilar Pipeline Progress
4:24pm
8-K
EX-99.1
5g2hfa
24 Feb 21
Coherus BioSciences Reports Fourth Quarter and Full Year 2020 Financial Results
4:05pm
8-K
EX-99.1
k0o0ggfqvmyj797
2 Feb 21
Entry into a Material Definitive Agreement
8:45am
8-K
EX-99.2
fi6krlij2
2 Feb 21
Entry into a Material Definitive Agreement
8:45am
8-K
EX-99.1
krdnc7
5 Nov 20
Coherus BioSciences Reports Third Quarter 2020 Financial Results
4:07pm
8-K
EX-99.1
wul3nu0honp52 x2us
6 Aug 20
Coherus BioSciences Reports Second Quarter 2020 Financial Results
4:07pm
8-K
EX-99.1
nlde05p603g fre4h6
7 May 20
Coherus BioSciences Reports First Quarter 2020 Financial Results
4:02pm